Sabra Healthcare REIT (SBRA) has been under a strong bear grip, hence the stock is down -1.61% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 2.02% in the past 1 week. The stock has risen by 2.19% in the past week indicating that the buyers are active at lower levels, but the stock is down -2.14% in the past 4 weeks.
The stock has recorded a 20-day Moving Average of 2.72% and the 50-Day Moving Average is 3.14%.The 200 Day SMA reached 21.69%
Sabra Healthcare REIT (NASDAQ:SBRA): The stock opened in the green at $25.28 on Friday, but the bulls found it difficult to push the prices higher. The stock reached a high of $25.47 and a low of $25.09 for the day. The stock did not find buyers even at the lows and closed at $25.18 recording a loss of -0.20%. 889,659 shares exchanged hands during the trading day. The stock had closed at $25.18 in the previous days trading.
Sabra Healthcare REIT (SBRA) : The highest short term price target forecast on Sabra Healthcare REIT (SBRA) is $30 and the lowest target price is $20. A total of 8 equity analysts are currently covering the company. The average price of all the analysts is $25 with a standard deviation of $3.93.
Sabra Health Care REIT, Inc. (Sabra) is a self-administered, self-managed real estate investment trust (REIT). Through its subsidiaries, the Company owns and invests in real estate serving the healthcare industry. The Company is primarily engaged in leasing healthcare properties to tenants and operators throughout the United States. It has a diverse portfolio of healthcare investments in the United States that offers a range of services, including skilled nursing/transitional care, assisted and independent living, mental health and acute care. The Companys investment portfolio consists of approximately 160 real estate properties held for investment, including 103 nursing/post-acute facilities, 55 senior housing facilities and two acute care hospitals; over 14 investments in loans receivable, including four mortgage loans, three construction loans, two mezzanine loans and five pre-development loans, and over six preferred equity investments.